Skip to main
DBD

DBD Stock Forecast & Price Target

DBD Analyst Ratings

Based on 2 analyst ratings
Buy
Strong Buy 50%
Buy 50%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Diebold Nixdorf is supported by a strengthening fundamental backdrop in both Retail and Banking, with Retail sales up 26% Y/Y in the quarter, NA pipeline growth tripling over the past year, and new wins in ePOS, SCO, and SmartVision AI suggesting the company is converting early customer interest into scalable deployments. On the Banking side, demand remains solid across North America, Europe, India, APAC, and Latin America, highlighted by major competitive displacements, 100% of a teller cash recycler install base won with one of the largest financial institutions in the U.S., and traction in fast-growing ATM markets such as India, while backlog rose sequentially to $790M. The company’s outlook is further reinforced by 1.2x net leverage, ~$680M of total liquidity, $21M of positive FCF in 1Q26 versus $6M in 1Q25, and ongoing margin and efficiency gains from lean practices and Oracle Field Services, all of which support buybacks, financial flexibility, and sustained execution.

Bears say

Diebold Nixdorf is a business with meaningful scale in ATMs and retail checkout systems, but its fundamentals are undermined by heavy concentration in the Banking segment, where large upgrade and replacement projects can create lumpy quarterly demand and weaker-than-expected activity can quickly pressure results. Its outlook is further clouded by the risk that it may not fully offset tariff-related costs, while supply chain, logistics, shipment, installation, and service disruptions can impair execution across both hardware and maintenance operations; FX volatility in the BRL, EUR, GBP, and other currencies adds another layer of earnings uncertainty. The company also faces notable liquidity and ownership overhang, with about $7M of average daily liquidity and roughly 60% of common shares controlled by debtholders after its Ch. 11 reorganization, which can amplify volatility if those holders reduce positions despite the positive momentum in Retail into 2026.

DBD has been analyzed by 2 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 50% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Diebold Nixdorf Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Diebold Nixdorf Inc (DBD) Forecast

Analysts have given DBD a Buy based on their latest research and market trends.

According to 2 analysts, DBD has a Buy consensus rating as of Oct 8, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $100, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $100, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Diebold Nixdorf Inc (DBD)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.